Wannenburg T, de Tombe P P, Little W C
Section on Cardiology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157-1045.
Am J Physiol. 1994 Oct;267(4 Pt 2):H1429-36. doi: 10.1152/ajpheart.1994.267.4.H1429.
We studied the effects of adenosine on oxygen consumption and contractile state in 17 isolated, crystalloid-perfused, isovolumically contracting rat heart preparations at constant coronary flow. In 10 experiments we determined adenosine-contractile state dose-response relationships in three groups of hearts using two different perfusates and in the presence and absence of adrenergic blockade. Adenosine consistently reduced contractile state in a dose-dependent fashion, reducing the ventricular pressure developed at a constant ventricular volume by 24% on average at its maximal effect. An adenosine concentration of 111 microM on average produced 50% of the maximal effect. In seven experiments we determined the end-systolic pressure-volume and oxygen consumption-pressure-volume area (MVO2-PVA) relationships at two calcium concentrations (1.5 and 0.75 mM) and with adenosine 400 microM (1.5 mM Ca2+). Contractile state was indexed by the developed pressure at a ventricular volume of 0.3 ml (P0.3). Compared with 1.5 mM Ca2+, mean P0.3 was reduced by 38% with 0.75 mM Ca2+ and by 18% with adenosine. Whereas the MVO2-PVA slopes did not change, the mean MVO2 intercept was reduced by 22% with 0.75 mM Ca2+ and by 13% with adenosine. The MVO2 intercept, which represents the oxygen consumed by the unloaded heart, was directly related to P0.3. This relationship, which represents the oxygen cost of contractility, was not affected by adenosine. We conclude that at constant coronary flow and perfusion pressure adenosine reduces myocardial contractility and the oxygen consumed for excitation-contraction coupling. However, adenosine does not affect the slope of the MVO2-PVA relation or the oxygen cost of contractility.(ABSTRACT TRUNCATED AT 250 WORDS)
我们研究了腺苷对17个离体、晶体灌注、等容收缩大鼠心脏标本在恒定冠脉血流情况下氧消耗和收缩状态的影响。在10个实验中,我们使用两种不同灌注液,在有无肾上腺素能阻断的情况下,测定了三组心脏中腺苷-收缩状态剂量反应关系。腺苷始终以剂量依赖方式降低收缩状态,在最大效应时,平均使恒定心室容积下产生的心室压力降低24%。平均111微摩尔/升的腺苷浓度产生最大效应的50%。在7个实验中,我们在两种钙浓度(1.5和0.75毫摩尔/升)以及腺苷400微摩尔/升(1.5毫摩尔/升钙离子)情况下,测定了收缩末期压力-容积和氧消耗-压力-容积面积(MVO2-PVA)关系。收缩状态以心室容积为0.3毫升时产生的压力(P0.3)为指标。与1.5毫摩尔/升钙离子相比,0.75毫摩尔/升钙离子使平均P0.3降低38%,腺苷使其降低18%。虽然MVO2-PVA斜率未改变,但0.75毫摩尔/升钙离子使平均MVO2截距降低22%,腺苷使其降低13%。代表无负荷心脏消耗氧的MVO2截距与P0.3直接相关。这种代表收缩性氧消耗的关系不受腺苷影响。我们得出结论,在恒定冠脉血流和灌注压力下,腺苷降低心肌收缩性以及兴奋-收缩偶联所消耗的氧。然而,腺苷不影响MVO2-PVA关系的斜率或收缩性的氧消耗。(摘要截短至250字)